# Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

> **NCT05789615** · — · COMPLETED · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 200 (actual)

## Conditions studied

- CMV Infection
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Letermovir

## Key facts

- **NCT ID:** NCT05789615
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2025-01-10
- **Final completion:** 2025-01-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789615, "Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05789615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*